Countdown to the 2023 Future Healthcare Technology Conference: First Batch of Speakers Announced
The recently released 2023 Nature Index rankings show that China has surpassed the United States for the first time, underscoring the rapid advancement of China’s scientific research capabilities and foundational research strength. Perhaps now, and in the near future, we should venture further into the vast, mysterious, and uncharted “no-man’s-land,” positioning ourselves as explorers, questioners, and pioneers.
November 30–December 1, 2023, the 2023 Future Healthcare Technology Conference will be held in Hefei.The conference will systematically review the 30 most noteworthy frontier technologies in the life and health sector, inviting research scholars aligned with these technological trends to share insights on emerging technical directions. It aims to create a technological feast featuring the release of cutting-edge technologies, the showcase of innovative tech products, and ecosystem collaboration among medical technology enterprises. Having been successfully held for three editions, this year’s conference is expected to invite100+ Most Influential Figures in Technology、100 Tech Companies、800 Professional AttendeesAttend the conference in person.
Scan the QR code to register and participate2023Future Healthcare Technology Conference
Time:11.30-12.1(For a duration of2days) 09:00-17:00
As the main forum of the 2023 Future Medical Technology Conference, the 2023 Future Medical Technology Trendsetter Summit will be divided into four sessions: the Opening Ceremony, Digital Technology, Biotechnology, and Intelligent Manufacturing. The event will focus on 30 major frontier technology trends and invite government officials, academicians from the Chinese Academy of Sciences and the Chinese Academy of Engineering, leading scholars in frontier technologies, corporate representatives, and renowned investors to participate.
Confirmed Attendees:
Xu Shuqiang| Former Director of the Department of System Reform, National Health Commission , Shanghai Jiao Tong UniversityChair Professor, Dean of the China Hospital Development Institute
Deng Zixin| Academician of the Chinese Academy of Sciences, Honorary Dean of the School of Life Sciences and Biotechnology, Shanghai Jiao Tong University
Yang Guangzhong| Fellow of the Royal Academy of Engineering, UK; Founder of the Medical Robotics Institute at Shanghai Jiao Tong University
Zhang Yuanting| Fellow of the International Academy of Medical and Biological Engineering, Chair Professor of Biomedical Engineering at City University of Hong Kong
Li Changming| Dean, School of Materials Science and Engineering, Suzhou University of Science and Technology; Academician of Academia Europaea
Zhou ShaohuaChair Professor, Executive Dean of the School of Biomedical Engineering, and Director of the Center for Intelligent Medical Imaging and Robotics at the University of Science and Technology of China
Xu Liqun| Chief Scientist, China Mobile Research Institute
Wang Guangyu| Doctoral Supervisor at Beijing University of Posts and Telecommunications, Executive Deputy Director of the Institute for Information Intelligence and Digital Health under the State Key Laboratory of Networking and Switching Technology, and the first post-1990s recipient of the "Explorer Prize"
Wei Hong| Professor, School of Basic Medical Sciences, Third Military Medical University; Chairperson, Committee on Gnotobiotic Animals, Chinese Association for Laboratory Animal Sciences
Hu Songnian| Chief Engineer of the Chinese Component of the Human Genome Project, Researcher at the Institute of Microbiology, Chinese Academy of Sciences
Fan Xiaohu| Dean of the Institute of Gene and Cell Therapy at Xi'an Jiaotong University, Former Chief Scientific Officer of Legend Biotech, Founder of Wandao Cell
Yang Maojun| Professor, School of Life Sciences, Tsinghua University; Researcher, Beijing Advanced Innovation Center for Structural Biology
Hong Liang| Director, Center for AI in Biomedicine, Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University; Chang Jiang Scholar of the Ministry of Education
Yang Hui| Founder and Chief Scientific Advisor of Huida Genomics, Recipient of the National Science Fund for Distinguished Young Scholars
Xu Song| Founder & Chairman of Lintek Bio, Chief Scientist of the National Key R&D Program, and one of the pioneers in the lncRNA field
Chi Bo| Professor at the State Key Laboratory of Materials-Oriented Chemical Engineering, Nanjing Tech University; Founder of HanNing Medical
Yuan Zezhi| Vice President of MSD China Healthcare, Head of Oncology Business Unit
Li Xin| Vice President of JD Health, General Manager of Technology
Li Li| President of Aier Eye Hospital
Liu Junwei| General Manager, Baidu AI Industry Department
Cai Jingyu| Partner, PwC Consulting
Wang Taifeng| Head of AI Algorithms at BioMap
Fang Cong| Founder and CEO of Shudan Technology
Liu Yueguang| Co-founder and Chief Scientific Officer of Nurogene
Qi Fei| Executive Director, Legend Capital
Li Datao| Founder of VCBeat
*Listed in no particular order; subject to actual conditions.
Time: November 30, 13:30–17:00
Following the release of the 2019 Catalogue for Guiding Industrial Structure Adjustment, the development and application of high-end medical devices, such as AI-assisted medical equipment, have once again been included in the 2023 Encouraged Category. This signifies that the integrated innovation of digital technologies and medical devices has become a major trend in the healthcare industry. This forum specially invites research experts, entrepreneurs in the intelligent medical device sector, and investors to comprehensively interpret the development progress of intelligent medical devices from the perspectives of policy, upstream and downstream industrial chains, and capital markets, while jointly exploring future trends and innovative pathways for intelligent medical devices.
Confirmed Guests:
Ji Yongnan| NVIDIA Director of Healthcare Industry, China
Dan Bo| MathWorks Chief Technology Officer, Medical Device Industry
Liu Dapeng| Chairman and CEO of Shanghai Weiyun Industrial Group
Ren Wenyong| Co-founder of Aibo Medical Robotics
Chen Yuemeng| Founder and Chairman of Mayo Cardio-Magnetic Medical Technology
Feng Yu| Founder and CEO of Jingwei Shida
Tang Haofu| Chairman of Chuangrui Investment
Chang Tingting| Partner at Qiushi Capital, CEO of Fenghuanggu Medical
*The order is not ranked; actual circumstances shall prevail.
Time: November 30, 13:30-17:00
Gene sequencing is one of the most prominent innovative technologies in cutting-edge science and clinical applications, and it represents a field rife with lucrative opportunities. Within a remarkably short period, gene sequencing technology has fostered a vast industrial chain, with upstream sectors comprising gene sequencers and their consumables, midstream sectors focused on sequencing and data services, and downstream sectors dedicated to research and clinical applications.This forum focuses on exploring the development of cutting-edge gene sequencing technologies and innovations in their applications.
Confirmed Guests:
Liu Longqi| Director of the Super Cell Institute at BGI Research, Chief Scientist of Single-Cell Omics, and Dean of Hangzhou BGI Research Institute
Peng Huanhuan| Vice President of MGI Tech, General Manager of China Marketing Center
Liang Zhikun | Deputy Dean, Daan Gene Research Institute
Zhang Xian| Chief Medical Officer, Geneseeq
Bai Jingwei| Co-founder and Chief Scientist of Qitan Technology
Zhang Yu| Chairman of Zhejiang Dipu Diagnostics
Yu WeiShi| Founder and CEO of Saifu Gene
Li Yishi| Partner, Haoyue Capital
*Listed in no particular order; subject to actual conditions.
Time: December 1, 09:00-12:00
With the explosive growth and diversification of medical data, artificial intelligence (AI) has become increasingly prevalent in healthcare. Over the past year, generative AI, as the most creative and imaginative branch of AI technology, has firmly captured the attention of healthcare professionals. This forum will invite research experts, leading AI companies, and top-tier investors to provide an in-depth analysis of the latest developments and applications of generative AI, as well as its future opportunities.
Confirmed Guests:
Li Yiming| Co-founder and CTO of Deepwise Medical
Su Li| Deputy General Manager of Yidu Cloud
Wei Yawei| General Manager of DingTalk's Healthcare Industry
Wu Di| CEO of Fuxin Sci-Tech Innovation
Xie Guanchao| President, Unisound Smart Healthcare Division
Yan Jun| CTO and Chief AI Scientist of Yidu Tech
Yang Ruirong| Partner, Yuan Yi Capital
Zhao Jing| Co-founder and Deputy General Manager of Dajing TCM
*Listed in alphabetical order by guest name; no ranking is implied. Actual arrangements shall prevail.
2023 FTC: The 5th China Frontier Technology Forum in Cardiac Surgery
Time: December 1, 09:00-17:00
Co-hosted by the Cardiac Surgery Technology and Engineering Committee of the China Medical Biotechnology Association and Peking Union Medical College Hospital, and co-organized by VCBeat, the “2023 FTC 5th Forum on Frontier Technologies in Cardiac Surgery” aims to bring together experts, scholars, corporate representatives, and industry professionals from China and abroad to jointly discuss technological advancements and development trends in cardiac surgery, as well as industrial innovation and collaboration opportunities.
Confirmed Guests:
Sun Lizhong| Shanghai DeltaHealth Hospital, Beijing Anzhen Hospital, Capital Medical University
Liu Zhao| Nanjing Drum Tower Hospital
Xiao Wei| Sichuan Science City Hospital
Ge Jianjun| Anhui Provincial Hospital
Sun Tucheng| Guangdong Provincial People's Hospital
Zheng Jun| Peking Union Medical College Hospital
Xu Shangdong| Beijing Affiliated Hospital of Capital Medical University
Liu Weiting| General Manager, Greater China, Abbott Structural Heart
Jin Lei| Chairman and General Manager of BaiRen Medical
*Listed in the order of guest speakers; no ranking is implied. Please refer to the actual schedule.*
The 3rd Conference of the Innovation and Translation Branch of Neurosurgery, China Association for Geriatric Health Care
Time: December 1, 09:00-17:00
Centered on the ITMNS Association’s clinical resources, the forum will collaborate with regulatory review agencies, innovative enterprises, financial capital, and other resources for innovation translation. Through activities such as white paper releases, awards for outstanding projects, and sharing of innovative practices, it aims to build a platform for in-depth exchange and win-win cooperation among experts, scholars, entrepreneurs, and other stakeholders in the field of neurosurgery, fostering dialogue on frontier trends in translational research and industrial innovation, as well as opportunities for application-oriented collaboration in China’s neurosurgery sector.
Confirmed Guests:
Zhang Jianning| Director, Department of Neurosurgery, Tianjin Medical University General Hospital
Wang Shuo| Vice Dean of the School of Neurosurgery, Capital Medical University; Chairman of the Chinese Society of Neurosurgery, Chinese Medical Association
Jiang Rongcai| Department of Neurosurgery, Tianjin Medical University General Hospital
Jiang Tianjiao| Dean of VCBeat Research Institute
Wu AnhuaExecutive Vice Dean, School of Innovation, China Medical University; Director, Department of Neurosurgery, The First Affiliated Hospital of China Medical University
Dong Miao| Clinical Translation Expert, Beijing Ensi Institute of Translational Medicine
Zhang Li| Chairman of Tianjin Jinxi Medical Equipment Co., Ltd.
Li Wei| General Manager of Tigermed Jietong Testing Laboratory, Senior Director of Tigermed Jietong Registration Department
Nie Hongxin| Managing Partner, Shanlan Capital
Mao Shuo| Executive Director, Qiming Venture Partners
Jia Yan丨Director, Healthcare and Life Sciences Division, China Renaissance
Lu Wei| Founding and Managing Partner, Enshe Capital
*Listed in no particular order; subject to actual conditions.
VB-Focus 2023 Future Healthcare Technology Innovation Award Call for Entries and Selection
VB-Focus is an evaluation framework launched this year by VB100 and VCBeat, focusing on the key forces driving breakthroughs in medical technology innovation. It aims to identify and uncover influential figures who are truly advancing the frontiers of medical technology. Submissions are open until November 16. (For more details, please seeVB-Focus Award Call for Entries Launched: The “Healthcare+” Era, a Barometer of Technological Trends in the Healthcare Industry）
